Pancreatic Cancer Research

ResearcherShanxi Medical UniversityNo recent work listed

Yongping Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8667-860X; OpenAlex author ID A5100714505. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 4

  1. MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value. Co-author DOI 10.1186/s12935-020-01529-9↗
  2. NETO2 promotes pancreatic cancer cell proliferation, invasion and migration via activation of the STAT3 signaling pathway. First author DOI 10.2147/cmar.s204260↗
  3. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes. Co-author DOI 10.18632/oncotarget.16249↗
  4. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells. Last author DOI 10.1016/j.diabres.2011.12.028↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yaxiong Li · 1 shared paper, 2019 · strength 0.16
  2. Jiansheng Liu · 1 shared paper, 2019 · strength 0.16
  3. Jiancheng Wang · 1 shared paper, 2020 · strength 0.13
  4. Xuejiao Wu · 1 shared paper, 2020 · strength 0.13
  5. Zilin Yang · 1 shared paper, 2020 · strength 0.13
  6. Weiyan Yao · 1 shared paper, 2020 · strength 0.13
  7. Yaozong Yuan · 2 shared papers, 2012–2017 · strength 0.12
  8. Yufen Zhou · 1 shared paper, 2017 · strength 0.08
  9. Xiangyi He · 1 shared paper, 2017 · strength 0.08
  10. Lei Wang · 1 shared paper, 2017 · strength 0.08
  11. Wei‐Guang Li · 1 shared paper, 2012 · strength 0.04
  12. Liya Huang · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.